These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 16300856)

  • 1. Vascular determinants of cholinergic deficits in Alzheimer disease and vascular dementia.
    Román GC; Kalaria RN
    Neurobiol Aging; 2006 Dec; 27(12):1769-85. PubMed ID: 16300856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of vascular dementia-evidence from clinical trials with cholinesterase inhibitors.
    Erkinjuntti T; Román G; Gauthier S
    Neurol Res; 2004 Jul; 26(5):603-5. PubMed ID: 15265282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison between Alzheimer's disease and vascular dementia: implications for treatment.
    Kalaria RN
    Neurol Res; 2003 Sep; 25(6):661-4. PubMed ID: 14503021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholinergic dysfunction in vascular dementia.
    Román GC
    Curr Psychiatry Rep; 2005 Mar; 7(1):18-26. PubMed ID: 15717981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alzheimer's disease is a vasocognopathy: a new term to describe its nature.
    de la Torre JC
    Neurol Res; 2004 Jul; 26(5):517-24. PubMed ID: 15265269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overlap between pathology of Alzheimer disease and vascular dementia.
    Kalaria RN; Ballard C
    Alzheimer Dis Assoc Disord; 1999; 13 Suppl 3():S115-23. PubMed ID: 10609690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrovascular damage as a cause for Alzheimer's disease.
    Humpel C; Marksteiner J
    Curr Neurovasc Res; 2005 Oct; 2(4):341-7. PubMed ID: 16181125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. β-Amyloid, cholinergic transmission, and cerebrovascular system -- a developmental study in a mouse model of Alzheimer's disease.
    Kuznetsova E; Schliebs R
    Curr Pharm Des; 2013; 19(38):6749-65. PubMed ID: 23530514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review: cerebral microvascular pathology in ageing and neurodegeneration.
    Brown WR; Thore CR
    Neuropathol Appl Neurobiol; 2011 Feb; 37(1):56-74. PubMed ID: 20946471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of vascular dementia--evidence from clinical trials with cholinesterase inhibitors.
    Erkinjuntti T; Román G; Gauthier S
    J Neurol Sci; 2004 Nov; 226(1-2):63-6. PubMed ID: 15537522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The rationale behind cholinergic drug treatment for dementia related to cerebrovascular disease.
    Grantham C; Geerts H
    J Neurol Sci; 2002 Nov; 203-204():131-6. PubMed ID: 12417371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular basis of Alzheimer's pathogenesis.
    de la Torre JC
    Ann N Y Acad Sci; 2002 Nov; 977():196-215. PubMed ID: 12480752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cholinergic deficit in Alzheimer's disease.
    Whitehouse PJ
    J Clin Psychiatry; 1998; 59 Suppl 13():19-22. PubMed ID: 9771826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity of cerebral blood flow in Alzheimer disease and vascular dementia.
    Yoshikawa T; Murase K; Oku N; Imaizumi M; Takasawa M; Rishu P; Kimura Y; Ikejiri Y; Kitagawa K; Hori M; Hatazawa J
    AJNR Am J Neuroradiol; 2003 Aug; 24(7):1341-7. PubMed ID: 12917125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropathological evaluation of mixed dementia.
    Jellinger KA; Attems J
    J Neurol Sci; 2007 Jun; 257(1-2):80-7. PubMed ID: 17324442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathological changes in neurovascular units: Lessons from cases of vascular dementia.
    Li C; Wang Y; Yan XL; Guo ZN; Yang Y
    CNS Neurosci Ther; 2021 Jan; 27(1):17-25. PubMed ID: 33423390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's disease and vascular dementia: one potentially preventable and modifiable disease. Part I: Pathology, diagnosis and screening.
    Davey DA
    Neurodegener Dis Manag; 2014; 4(3):253-9. PubMed ID: 25095819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Revisiting the cholinergic hypothesis of behavioral and psychological symptoms in dementia of the Alzheimer's type.
    Pinto T; Lanctôt KL; Herrmann N
    Ageing Res Rev; 2011 Sep; 10(4):404-12. PubMed ID: 21292041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance imaging-measured atrophy and its relationship to cognitive functioning in vascular dementia and Alzheimer's disease patients.
    Logue MW; Posner H; Green RC; Moline M; Cupples LA; Lunetta KL; Zou H; Hurt SW; Farrer LA; Decarli C;
    Alzheimers Dement; 2011 Sep; 7(5):493-500. PubMed ID: 21723205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small vessel disease to subcortical dementia: a dynamic model, which interfaces aging, cholinergic dysregulation and the neurovascular unit.
    Caruso P; Signori R; Moretti R
    Vasc Health Risk Manag; 2019; 15():259-281. PubMed ID: 31496716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.